< Back to Article
Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer
Figure 5
Galectin-3 knockdown sensitized MDA-MB-231 cells to ATO-induced apoptosis.
Cells were labeled with annexin V (x-axis) and PI (y-axis), and apoptosis was analyzed using a flow cytometer.
doi: https://doi.org/10.1371/journal.pone.0103482.g005